Ductal carcinoma in situ (DCIS) can be treated with surgery, or with Active Monitoring for low-risk DCIS. Chemotherapy is not needed, although sometimes radiation or hormone therapy are suggested. Most DCIS never develops into an invasive cancer. In part 2 of the DCIS webinar series, we will discuss where research is taking us. For those who have already received treatment and surgery, this will be essential information to learn and share with family and friends so they know their level of risk too. You can also share this information with your medical team to help them keep up with the latest DCIS research and care.
Our panelists, Dr. Shelley Hwang and Deborah Collyar, discussed ways to de-escalate the fear of recurrence and ways to ensure decisions are made without fear.